207 related articles for article (PubMed ID: 29749354)
1. Lymphatic filariasis elimination programme in Assam, India, needs change in mass drug administration strategy to target the focus of infection.
Khan AM
Indian J Med Res; 2018 Jan; 147(1):7-10. PubMed ID: 29749354
[No Abstract] [Full Text] [Related]
2. Coverage survey for assessing mass drug administration against lymphatic filariasis in Gulbarga district, Karnataka, India.
Ranganath BG
J Vector Borne Dis; 2010 Mar; 47(1):61-4. PubMed ID: 20231778
[No Abstract] [Full Text] [Related]
3. Lymphatic filariasis elimination programme in India: progress and challenges.
Ramaiah KD
Trends Parasitol; 2009 Jan; 25(1):7-8. PubMed ID: 19008150
[No Abstract] [Full Text] [Related]
4. Lymphatic filariasis in Andhra Pradesh Paper Mill Colony, Rajahmundry, India after nine rounds of MDA programme.
Mukhopadhyay AK
J Vector Borne Dis; 2010 Mar; 47(1):55-7. PubMed ID: 20231775
[No Abstract] [Full Text] [Related]
5. Evidence for the use of albendazole for the elimination of lymphatic filariasis.
Sunish IP; Rajendran R; Mani TR; Dash AP; Tyagi BK
Lancet Infect Dis; 2006 Mar; 6(3):125-6. PubMed ID: 16500593
[No Abstract] [Full Text] [Related]
6. Towards elimination of lymphatic filariasis in India.
Das PK; Ramaiah KD; Augustin DJ; Kumar A
Trends Parasitol; 2001 Oct; 17(10):457-60. PubMed ID: 11587940
[TBL] [Abstract][Full Text] [Related]
7. Measuring impact on filarial infection status in a community study: role of coverage of mass drug administration (MDA).
Kumar A; Sachan P
Trop Biomed; 2014 Jun; 31(2):225-9. PubMed ID: 25134891
[TBL] [Abstract][Full Text] [Related]
8. Elimination of lymphatic filariasis.
Michael E; Malecela-Lazaro MN; Kazura JW
Lancet; 2006 Jul; 368(9533):362-3; author reply 363-4. PubMed ID: 16876654
[No Abstract] [Full Text] [Related]
9. New goals set for filariasis elimination in India.
Sharma DC
Lancet Infect Dis; 2002 Jul; 2(7):389. PubMed ID: 12127343
[No Abstract] [Full Text] [Related]
10. Sustainability of soil-transmitted helminth control following a single-dose co-administration of albendazole and diethylcarbamazine.
Rajendran R; Mani TR; Munirathinam A; Sunish IP; Abdullah SM; Augustin DJ; Satyanarayana K
Trans R Soc Trop Med Hyg; 2003; 97(3):355-9. PubMed ID: 15228259
[TBL] [Abstract][Full Text] [Related]
11. Decline in lymphatic filariasis transmission with annual mass drug administration using DEC with and without albendazole over a 10year period in India.
Sunish IP; Kalimuthu M; Rajendran R; Munirathinam A; Ashok Kumar V; Nagaraj J; Tyagi BK
Parasitol Int; 2015 Feb; 64(1):1-4. PubMed ID: 25205435
[TBL] [Abstract][Full Text] [Related]
12. Knowledge on lymphatic filariasis and mass drug administration (MDA) programme in filaria endemic districts of Andhra Pradesh, India.
Mukhopadhyay AK; Patnaik SK; Satya Babu P; Rao KN
J Vector Borne Dis; 2008 Mar; 45(1):73-5. PubMed ID: 18399322
[No Abstract] [Full Text] [Related]
13. Diethylcarbamazine citrate-fortified salt for lymphatic filariasis elimination in India.
Sabesan S; Krishnamoorthy K; Hoti SL; Subramanian S; Srividya A; Roy N; Jain T; Kumar A; Rahi M
Indian J Med Res; 2022 Mar; 155(3&4):347-355. PubMed ID: 36124509
[TBL] [Abstract][Full Text] [Related]
14. Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India.
Rajendran R; Sunish IP; Mani TR; Munirathinam A; Arunachalam N; Satyanarayana K; Dash AP
Trop Med Int Health; 2006 Jun; 11(6):851-61. PubMed ID: 16772007
[TBL] [Abstract][Full Text] [Related]
15. Coverage and compliance of mass drug administration (MDA) programme for elimination of lymphatic filariasis in an endemic district of eastern Uttar Pradesh, India.
Bashar A; Nandekar SV; Shrivastava P; Singh RN; Srikrishnan P
J Vector Borne Dis; 2023; 60(3):307-316. PubMed ID: 37843242
[TBL] [Abstract][Full Text] [Related]
16. Elimination of lymphatic filariasis in India.
Sabesan S; Ravi R; Das PK
Lancet Infect Dis; 2005 Jan; 5(1):4-5. PubMed ID: 15620551
[No Abstract] [Full Text] [Related]
17. Introduction of Triple-Drug Therapy for Accelerating Lymphatic Filariasis Elimination in India: Lessons Learned.
Tripathi B; Roy N; Dhingra N
Am J Trop Med Hyg; 2022 May; 106(5_Suppl):29-38. PubMed ID: 35292580
[TBL] [Abstract][Full Text] [Related]
18. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.
Babu BV; Kar SK
Trop Med Int Health; 2004 Jun; 9(6):702-9. PubMed ID: 15189460
[TBL] [Abstract][Full Text] [Related]
19. Lymphatic filariasis.
Wkly Epidemiol Rec; 2003 May; 78(20):171-9. PubMed ID: 12808788
[No Abstract] [Full Text] [Related]
20. Lymphatic pathology in asymptomatic and symptomatic children with Wuchereria bancrofti infection in children from Odisha, India and its reversal with DEC and albendazole treatment.
Kar SK; Dwibedi B; Das BK; Agrawala BK; Ramachandran CP; Horton J
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005631. PubMed ID: 29059186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
